Clinical Trials and Research Funding Support the Heart Failure POC & LOC Devices Market
Hospitals and clinics are the backbone of healthcare delivery, and their adoption of innovative diagnostics fuels growth in the Heart Failure POC & LOC Devices Market.
The market, valued at USD 110.5 million in 2021, is expected to nearly double by 2030, reaching USD 225.1 million at a CAGR of 8.2%. Institutional adoption is one of the strongest contributors to this growth.
Hospitals adopt these devices to reduce patient waiting times, improve accuracy, and optimize clinical workflows. Clinics, particularly outpatient centers, use POC and LOC devices to deliver quick results that support immediate decision-making.
With rising patient volumes, especially in cardiology departments, portable diagnostics streamline care while lowering operational costs. These adoption trends also support decentralized care models, where patients receive high-quality diagnostics outside traditional lab settings.
As hospitals and clinics continue modernizing, their reliance on advanced diagnostic devices will only strengthen.